Skip to main content
. 2025 Jan 3;74(2):54. doi: 10.1007/s00262-024-03888-y

Fig. 6.

Fig. 6

Safety profiles. A The cytotoxicity of the four mRNA-LNPs used in the study was detected using CCK-8 kit. B AST and ALT activities in peripheral blood were measured in tumor-bearing mice treated with PBS, mTubulin mRNA-LNP, and vaccine. C AST and ALT activities in peripheral blood were evaluated in mice immunized with PBS, mTubulin mRNA-LNP, and vaccine. Data are shown as mean values ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001